4.7 Article

Prevalence and Severity of Coronary Artery Disease and Adverse Events Among Symptomatic Patients With Coronary Artery Calcification Scores of Zero Undergoing Coronary Computed Tomography Angiography Results From the CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter) Registry

期刊

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
卷 58, 期 24, 页码 2533-2540

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacc.2011.10.851

关键词

computed tomography; coronary artery disease; coronary calcium score; coronary computed tomography angiography; prognosis

资金

  1. Siemens
  2. Bayer Schering Pharma
  3. GE Healthcare
  4. Bayer Pharma
  5. Blue Cross Blue Shield Blue Care MI
  6. Pfizer
  7. AstraZeneca
  8. Swiss National Science Foundation

向作者/读者索取更多资源

Objectives The purpose of this study was to describe the prevalence and severity of coronary artery disease (CAD) in relation to prognosis in symptomatic patients without coronary artery calcification (CAC) undergoing coronary computed tomography angiography (CCTA). Background The frequency and clinical relevance of CAD in patients without CAC are unclear. Methods We identified 10,037 symptomatic patients without CAD who underwent concomitant CCTA and CAC scoring. CAD was assessed as <50%, >= 50%, and >= 70% stenosis. All-cause mortality and the composite end-point of mortality, myocardial infarction, or late coronary revascularization (>= 90 days after CCTA) were assessed. Results Mean age was 57 years, 56% were men, and 51% had a CAC score of 0. Among patients with a CAC score of 0, 84% had no CAD, 13% had nonobstructive stenosis, and 3.5% had >= 50% stenosis (1.4% had >= 70% stenosis) on CCTA. A CAC score >0 had a sensitivity, specificity, and negative and positive predictive values for stenosis >= 50% of 89%, 59%, 96%, and 29%, respectively. During a median of 2.1 years, there was no difference in mortality among patients with a CAC score of 0 irrespective of obstructive CAD. Among 8,907 patients with follow-up for the composite endpoint, 3.9% with a CAC score of 0 and >= 50% stenosis experienced an event (hazard ratio: 5.7; 95% confidence interval: 2.5 to 13.1; p < 0.001) compared with 0.8% of patients with a CAC score of 0 and no obstructive CAD. Receiver-operator characteristic curve analysis demonstrated that the CAC score did not add incremental prognostic information compared with CAD extent on CCTA for the composite endpoint (CCTA area under the curve = 0.825; CAC + CCTA area under the curve = 0.826; p = 0.84). Conclusions In symptomatic patients with a CAC score of 0, obstructive CAD is possible and is associated with increased cardiovascular events. CAC scoring did not add incremental prognostic information to CCTA. (J Am Coll Cardiol 2011;58:2533-40) (C) 2011 by the American College of Cardiology Foundation

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据